Oaktree Acquisition Corp. III Life Sciences (OACC) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
OACC currently has 19.2M outstanding shares. with significant dilution risk as 17.7M authorized shares could dilute existing holders by 91.9%. The company has significantly diluted shareholders by 281.6% over the past 2 years, indicating aggressive capital raising.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Nov 13, 2025 |
10-Q filing | 19.2M shares outstanding |
19M | 18M |
| May 14, 2025 |
10-Q filing | 19.2M shares outstanding |
19M | 18M |
| Oct 18, 2024 |
S-1/A filing: Oaktree Acquisition Corp. III Life Sciences is offering 17,500,000 units, each consisting of one Class A ordinary share and one-fifth of one redeemable warrant, at a price of $10.00 per unit in an initial public offering. |
5M | 18M |
| Oct 04, 2024 |
S-1 filing: S-1 filing for an offering of units at $10.00 per unit, with a total proposed amount of $175,000,000. |
N/A | 18M |